Trial intelligence / Profile preview

Intravenous amiodarone versus procainamide for tolerated regular wide-QRS tachycardia

2005-001505-25Phase 4Active

Sponsor
Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in ventricular tachycardia (VT) comparing Intravenous amiodarone with Intravenous procainamide (2 arms). Primary endpoint: Significant cardiac adverse events during study period. Started May 2006; status: active.

02

Drugs

amiodaroneprocainamide
03

Conditions

ventricular tachycardia (VT)

Beyond the preview

Go deeper on 2005-001505-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001505-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call